OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION is a Kit in the Human Prescription Drug category. It is labeled and distributed by Omp, Inc.. The primary component is .
| Product ID | 62032-518_aba5eec8-1945-4753-b301-bc612936cec1 | 
| NDC | 62032-518 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION | 
| Generic Name | Hydroquinone, Octinoxate And Zinc Oxide | 
| Dosage Form | Kit | 
| Marketing Start Date | 2012-11-07 | 
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER | 
| Labeler Name | OMP, INC. | 
| Active Ingredient Strength | 0 | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2018-12-31 | 
| Marketing Start Date | 2012-11-07 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2012-11-07 | 
| Inactivation Date | 2020-01-31 | 
| SPL SET ID: | 892bbe2c-cc50-4aea-99f1-0bcd1151f266 | 
| Manufacturer | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 62032-535 | OBAGI-C RX System NORMAL-DRY SKIN INTERVENTION | OBAGI-C RX System NORMAL-DRY SKIN INTERVENTION | 
| 62032-508 | CONDITION AND ENHANCE SYSTEM | HYDROQUINONE, OCTINOXATE AND ZINC OXIDE | 
| 62032-509 | CONDITION AND ENHANCE SYSTEM | HYDROQUINONE, OCTINOXATE AND ZINC OXIDE | 
| 62032-500 | NU-DERM TRAVEL SET NORMAL/DRY | HYDROQUINONE, OCTINOXATE AND ZINC OXIDE | 
| 62032-518 | OBAGI-C RX SYSTEM NORMAL-DRY | HYDROQUINONE, OCTINOXATE AND ZINC OXIDE | 
| 62032-524 | OBAGI-C RX SYSTEM NORMAL-DRY | HYDROQUINONE, OCTINOXATE AND ZINC OXIDE | 
| 62032-517 | OBAGI-C RX SYSTEM NORMAL-OILY | HYDROQUINONE, OCTINOXATE AND ZINC OXIDE | 
| 62032-523 | OBAGI-C RX SYSTEM NORMAL-OILY | HYDROQUINONE, OCTINOXATE AND ZINC OXIDE |